Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-26 @ 4:21 PM
Study NCT ID:
NCT05675033
Status:
UNKNOWN
Last Update Posted:
2023-01-09
First Post:
2022-12-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma
Sponsor:
Fujian Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-01-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-01-10
Completion Date Type:
ESTIMATED
First Submit Date:
2022-12-06
First Submit QC Date:
None
Study First Post Date:
2023-01-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-21
Last Update Post Date:
2023-01-09
Last Update Post Date Type:
ACTUAL